We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Phase 2a Study Initiated Evaluating RV521 for RSV

News   Sep 05, 2017 | Original story from ReViral Ltd

 
Phase 2a Study Initiated Evaluating RV521 for Respiratory Syncytial Virus Infection
 
 
 

RELATED ARTICLES

Regular Use of Prescription Meds for Pain and Sleep Increases Frailty Risk by 95%

News

Researchers have demonstrated statistically significant associations between self-reported regular use of prescription drugs for pain and/or sleep, and longitudinal risk of frailty in adults 65 years and over.

READ MORE

Mathematical Method Provides Deeper Understanding of Drug Interactions

News

Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences have developed a new methodology characterizing more precisely how drugs influence each other when combined during treatment.

READ MORE

Could Anthrax Help Fight Bladder Cancer?

News

A team from Purdue University has come up with a way to combine the anthrax toxin with a growth factor to kill bladder cancer cells and tumors.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE